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Cerebral small vessel disease-related brain lesions such as white matter lesions and lacunes are common findings of magnetic
resonance imaging in the elderly. These lesions are thought to be major contributors to disability in old age, and risk factors that
include age and hypertension have been established. The radiological, histopathologic and clinical phenotypes of age-related
cerebral small vessel disease remarkably resemble autosomal dominant arteriopathy with subcortical infarcts and leucoence-
phalopathy, which is caused by mutations in NOTCH3. We hypothesized that genetic variations in NOTCH3 also play a role in
age-related cerebral small vessel disease. We directly sequenced all 33 exons, the promoter and 30-untranslated region of
NOTCH3 in 195 participants with either coalescent white matter lesions or lacunes and compared the results to 82 randomly
selected participants with no focal changes on magnetic resonance images in the Austrian Stroke Prevention Study. We detected
nine common and 33 rare single nucleotide polymorphisms, of which 20 were novel. All common single nucleotide polymorph-
isms were genotyped in the entire cohort (n = 888), and four of them, rs1043994, rs10404382, rs10423702 and rs1043997, were
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associated significantly with both the presence and progression of white matter lesions. The association was confined to
hypertensives, a result which we replicated in the Cohorts for Heart and Ageing Research in Genomic Epidemiology
Consortium on an independent sample of 4773 stroke-free hypertensive elderly individuals of European descent (P = 0.04).
The 33 rare single nucleotide polymorphisms were scattered over the NOTCH3 gene with three being located in the promoter
region, 24 in exons (18 non-synonymous), three in introns and three in the 30-untranslated region. None of the single nucleotide
polymorphisms affected a cysteine residue. Sorting Intolerant From Tolerant, PolyPhen2 analyses and protein structure simula-
tion consistently predicted six of the non-synonymous single nucleotide polymorphisms (H170R, P496L, V1183M, L1518M,
D1823N and V1952M) to be functional, with four being exclusively or mainly detected in subjects with severe white matter
lesions. In four individuals with rare non-synonymous single nucleotide polymorphisms, we noted anterior temporal lobe
hyperintensity, hyperintensity in the external capsule, lacunar infarcts or subcortical lacunar lesions. None of the observed
abnormalities were specific to cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy.
This is the first comprehensive study investigating (i) the frequency of NOTCH3 variations in community-dwelling elderly and
(ii) their effect on cerebral small vessel disease related magnetic resonance imaging phenotypes. We show that the NOTCH3
gene is highly variable with both common and rare single nucleotide polymorphisms spreading across the gene, and that
common variants at the NOTCH3 gene increase the risk of age-related white matter lesions in hypertensives. Additional
investigations are required to explore the biological mechanisms underlying the observed association.
Keywords: NOTCH3; cerebral small vessel disease; genetics; MRI; ageing
Abbreviations: AGES = Ageing Gene–Environment Susceptibility-Reykjavik Study; ARIC = Atherosclerosis Risk in Communities
Study; CADASIL = cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy; CHARGE = cohorts
for heart and ageing research in genomic epidemiology consortium; NCBI = National Centre for Biotechnology Information;
SIFT = Sorting Intolerant From Tolerant; SNP = single nucleotide polymorphism
Introduction
Correlates of age-related cerebral small vessel disease, such as
white matter lesions and lacunes are common (Launer et al.,
2006), can progress rapidly (Schmidt et al., 2007) and are asso-
ciated with cognitive impairment (Breteler et al., 1994; Longstreth
et al., 2005) to dementia (O’Brien et al., 2003; Vermeer et al.,
2003b), gait disturbances and falls (Rosano et al., 2006; Srikanth
et al., 2009). They are also predictors of future disability (Inzitari
et al., 2009). Besides age and arterial hypertension, causative fac-
tors are widely unknown (O‘Brian et al., 2003). The estimated
heritability index of white matter lesions is in the range of
55–73% (Carmelli et al. 1998; Atwood et al., 2004), which is a
clear indication that genetic factors play a major aetiological
role. Age-related cerebral small vessel disease shows remarkable
radiological and histopathological similarities with cerebral
autosomal dominant arteriopathy with subcortical infarcts and
leucoencephalopathy (CADASIL), a monogenic form of systemic
non-amyloid arteriopathy primarily affecting the brain (Adib-Samii
et al., 2010; Chabriat et al., 1995, 2009; Joutel et al., 1996;
Dichgans et al., 1998; Desmond et al., 1999; Reyes et al., 2009).
CADASIL is caused by mutations in the NOTCH3 gene (Joutel
et al., 1996). Notch3 plays a key role in the functional and struc-
tural integrity of small arteries by regulating vascular smooth
muscle cell differentiation, maturation and phenotypic behaviour
(Artavanis-Tsakonas et al., 1999; Domenga et al., 2004; Wang
et al., 2008). We hypothesized that Notch3 not only plays a role
in CADASIL but is also involved in the development of age-related
cerebral small vessel disease, with both common and rare single
nucleotide polymorphisms (SNPs) of the NOTCH3 gene contribut-
ing to the risk of this multi-factorial disorder. We took a two step
approach to evaluate this hypothesis in the setting of the Austrian
Stroke Prevention Study. First, we screened the promoter, the
coding and the 3’ untranslated region of the NOTCH3 gene for
the presence of mutations in all individuals with either coalescent
white matter lesions or lacunes and compared the frequency of
genetic variants to a random subset of participants from the
Austrian Stroke Prevention Study who were free from focal lesions
on MRI. We then genotyped the whole cohort (n = 888) for the
observed common SNPs (minor allele frequency5 5%) and as-
sessed their association with the presence of white matter lesions
and lacunes as a primary phenotype and white matter lesion pro-
gression as a secondary phenotype. We sought to replicate our
finding in an independent sample of 8545 stroke-free individuals
of European descent in the Cohorts for Heart and Ageing Research
in Genomic Epidemiology (CHARGE) Consortium including six
community-based cohorts with brain MRI scans and genome-wide
genotype data (Fornage et al., 2011). We further elucidated the
effects of the rare (minor allele frequency 55%) non-synonymous
SNPs in the NOTCH3 gene by studying their association with
CADASIL-specific clinical and MRI characteristics and by analysing
the possible functionality of non-synonymous SNPs using bioinfor-
matical tools.
Materials and methods
Study population
The Austrian Stroke Prevention Study is a prospective cohort
study on the effects of vascular risk factors on brain structure
and function in cognitively normal middle-aged and elderly
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inhabitants of Graz, Austria; details have previously been described
(Schmidt et al., 1994, 1999). Briefly, participants (n = 2007) were
selected randomly from the official community register and all
participants were free from stroke and dementia. The study proto-
col was approved by the responsible ethics committee. In an initial
study panel that took place between 1991 and 1994, subjects
(n = 509) randomly selected from the entire cohort underwent
an extended diagnostic work-up including brain MRI and cognitive
testing. To enlarge the cohort with imaging and neuropsychologic-
al assessments, an additional 567 individuals were selected
randomly in a second panel between 1999 and 2003. They under-
went identical imaging and cognitive test procedures. Participants
of the first and second panels were pooled, which resulted in a
total of 1076 individuals with brain MRI and neuropsychological
evaluation. Clinical history, blood tests, MRI and cognitive assess-
ments were always performed on the same day. Historic informa-
tion and laboratory findings at baseline were considered for risk
factor diagnosis. The definitions have previously been described
(Schmidt et al., 1999). A history of migraine was taken in all
study participants and all individuals underwent dementia screen-
ing by the Mini-Mental State Examination (Folstein et al., 1975).
For assessment of depressive mood, we applied the
‘Eigenschaftswo¨rterliste’, a validated multi-dimensional tool con-
sisting of a list of given adjectives describing the emotional state
of a person (Janke, 1978). In the present study, 888 participants
of the Austrian Stroke Prevention Study with brain MRI and DNA
samples were included. Their mean age was 65.2  8.0 years.
There were 505 (56.9%) women. Mean systolic blood pres-
sure from three measurements taken during clinical examination
was 143.8  23.16 mmHg (range 85–220), mean diastolic
blood pressure was 87.7  10.32 mmHg (range 60–123).
Hypertensives were defined as having a mean systolic blood pres-
sure 5140 mmHg or a diastolic blood pressure 590 mmHg or
being on anti hypertensive therapy. A total of 641 (72.2%) par-
ticipants were hypertensive and 251 (23.3%) were on antihyper-
tensive therapy. In total, 86 (9.7%) had diabetes and 304 (34.2%)
had cardiac disease based on clinical, ECG and echocardiography
results. Altogether, 152 (17.1%) subjects reported migraine and
91 (10.2%) reported depressed mood. The mean Mini-Mental
State Examination score of the sample was 27.4  1.7. At least
one follow-up examination at 3 and 6 years with identical proto-
cols was carried out in 534 subjects. There were 500 and 300
subjects with 3- and 6-year follow-up MRI scans, respectively.
Magnetic resonance imaging
All scans were obtained on a 1.5 Tesla scanner (Philips Medical
Systems) with protocols described previously (Schmidt et al.,
1999). White matter lesion grade, volume and lacunes were deter-
mined in each study participant at baseline and follow-ups. White
matter lesions were assessed by two experienced investigators
(R.S. and C.E.). There were 717 (80.7%) participants with white
matter lesions of any grade. In total, 195 (21.9%) subjects had
early confluent or confluent lesions. The methods used for volume
measurements have been described elsewhere (Schmidt et al.,
1999, 2005). Mean white matter lesion load was 3.04 cm3
(range 0–78) at baseline investigation. The annual change of
white matter lesion volume was calculated by dividing the volume
change by years of follow-up. The mean annual change in white
matter lesion load observed in our study participants was 0.22 cm3
(range 0–4.99). Lacunes were defined as focal lesions that
involved the basal ganglia, internal capsule, thalamus or brain-
stem, not exceeding a maximum diameter of 15 mm and occurred
in 80 (9.2%) subjects. Incident lacunes at any follow-up were
determined by direct comparison of baseline and follow-up
scans. Incident lacunes were seen in 10 (2.0%) study participants.
In carriers of rare non-synonymous SNPs, MRI images were also
reviewed for findings suggestive of CADASIL. These included
anterior temporal lobe hyperintensity, hyperintensity of the exter-
nal capsule and subcortical lacunar lesions (Markus et al., 2002;
van den Boom et al., 2003). As in subjects with common SNPs,
we also recorded lacunes, white matter lesion volume at baseline
and annual progression of lesions in this subset of participants.
Microbleeds could not systematically be assessed as only a small
portion of participants in the Austrian Stroke Prevention Study
underwent MRI with gradient echo sequences.
DNA analyses
DNA sampling
Genomic DNA was extracted from ethylenediaminetetraacetic
acid–blood using the standard phenol/chloroform method. A por-
tion of the genomic DNA was amplified by REPLI-g Screening Kit
(QIAGEN) and was used as template for the mutation screening.
The original genomic DNA was used for confirmatory sequencing
of detected SNPs and for genotyping the common SNPs using the
TaqMan assay.
Mutation screening
The promoter, all 33 exons (including the intronic flanking regions)
and 30-untranslated regions were amplified by PCR in separate
reactions. Exon 24 was subdivided into two overlapping PCRs
(24–1, 24–2) and exon 33 into 6 overlapping PCRs (33–1, 33–6).
The PCR products were then purified with Wizard SV Gel and
PCR Clean-up kit as prescribed by Promega, verified by gel electro-
phoresis and sequenced using BigDye Terminator v1.1 Cycle
Sequencing (Applied Biosystems) on a 3730 DNA Analyser (Applied
Biosystems/HITACHI). All reagents, PCR primers and conditions are
given in the Supplementary material. Electropherograms were ana-
lysed with the SeqScape v2.5 (Applied Biosystems) and the
Sequencing Analysis 5.2 (Applied Biosystems) algorithms. The mes-
senger RNA sequence of the National Centre for Biotechnology
Information (NCBI; accession number NM_000435, version
NM_000435.2) was used as the reference sequence and for num-
bering of mutations at the DNA level. The corresponding amino
acid sequence originated from GenBank (accession number
U97669, version U97669.1), positions of the mutations are
given related to the ATG translation start site at the protein level.
For the final annotation of detected common SNPs, The Single
Nucleotide Polymorphism database of the NCBI was used
(www.ncbi.nlm.nih.gov/SNP/). All samples showing a sequence
alteration during the screening procedure were resequenced
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using genomic DNA as a template in both 30 and 50 directions in
order to define mutations with high confidence.
Genotyping of common single nucleotide
polymorphisms
Real-time PCR with sequence-specific TaqMan probes (Ingenetix;
Vienna, Austria) were used for genotyping common SNPs (minor
allele frequency 55%; rs11882186, rs1043994, rs61749020,
rs10423702, rs1043996, rs1043997, rs1044006, rs4809030 and
rs1044009) in 888 participants of the Austrian Stroke Prevention
Study cohort for whom both MRI and DNA samples were avail-
able. TaqMan assays were analysed on a 7900HT Fast Real-time
PCR system (Applied Biosystems). Detailed genotyping conditions
are given in the Supplementary material. One common SNP at the
NOTCH3 gene, rs10404382, was genotyped earlier on the Illumina
Human610-Quad BeadChip and was also included in the analyses.
Functional assessment of rare single
nucleotide polymorphisms
Sorting Intolerant From Tolerant and PolyPhen2
The Sorting Intolerant From Tolerant (SIFT) algorithm (J. Craig
Venter Institute, version 4.0.3) was used to predict whether
rare SNPs affect the Notch3 protein function. SIFT uses sequence
homology for calculating whether an amino acid substitution at a
given position is tolerated or affects the protein function.
Substitutions are more tolerated at positions with low conserva-
tion and more intolerant with high conservation. In order to get
related homologous sequences for the input query sequence, a
Basic Local Alignment Search Tool search was performed using
the NCBI non-redundant database. Only related sequences with a
maximum identity percentage of 90 were used for this analysis.
SIFT is available at http://sift.jcvi.org.
PolyPhen2, a revised version of PolyPhen, allows prediction of
the impact of missense mutations on the function of encoded
proteins by performing various sequence and structure analyses,
yielding a probability of altered function. We have used the data
set HumDiv to test and train the predictions made by PolyPhen2.
Predictions are characterized as either benign, possibly damaging
or probably damaging on the output. PolyPhen2 is available at
http://genetics.bwh.harvard.edu/pph2.
Protein simulation by homology
modelling and threading
The 3D structure of Notch3 was not available in the Protein Data
Bank database (Sussman, 1999). Therefore, parts of the structure
have been determined by homology modelling and threading.
Homology modelling is a knowledge-based structure prediction
where a protein sequence with an unknown structure (the target)
is aligned with one or more protein sequences with known struc-
tures (the templates). By the threading method, the sequence with
an unknown structure is fitted into a variety of existing structures.
The model building can be done by using profile–profile matching
and secondary structure. The homology modelling was done with
SWISS-MODEL and the threading with Phyre (Protein HomologY
Recognition Engine), a successor of 3D-PSSM (Kelley and
Sternberg, 2009). To study putative structural effects of the
mutations, the affected residues inside the domains of Notch3
were interchanged and an energy minimization was performed.
These replacements were performed on the Swiss-Pdb viewer
(Guex and Peitsch, 1997). The structural changes due to the mu-
tations are visualized and the energy of the molecular force field
(GROMOS96 force field) calculated (Li et al., 2008).
Statistical analyses
Genotypes were coded according to the minor alleles as 0 for
homozygous for the major allele, 1 for heterozygous and 2 for
homozygous for the minor allele. All common SNPs were tested
for Hardy Weinberg equilibrium. The linkage disequilibrium plot
was drawn using common SNPs genotyped in the Austrian
Stroke Prevention Study cohort by HaploView 4.2 (Barrett et al.,
2005) using the standard (D0/LOD) linkage disequilibrium colour
scheme. Linkage disequilibrium values are given by R2. The haplo-
type blocks were estimated using the ‘solid spine of LD’ method,
which defines haplotype blocks by the first and the last SNPs
being in strong linkage disequilibrium with all intermediate mark-
ers. Linkage disequilibrium does not necessarily appear between
intermediate SNPs. Linear trend test with 1 degree of freedom was
used to assess the effect of genotypes on the presence of white
matter lesions and lacunes assuming additive genetic effects.
Logistic regression analyses were used to assess the association be-
tween the common SNPs and the presence of white matter lesions
as well as lacunes upon adjustment for age (Model 1) and age,
sex, hypertension, cardiac disease and diabetes (Model 2).
Multiple linear regressions were used to assess the effect of com-
mon SNP genotypes on the annual change of white matter lesion
volume, as measure of white matter lesions progression upon ad-
justment for age (Model 1) and age, sex, hypertension, cardiac
disease and diabetes (Model 2). Both regression analyses were also
conducted with stratifications for hypertension (yes/no).
Replication
The replication sample comprised 8545 individuals of European des-
cent (aged 69.5 years; 42.6% men) belonging to six community-
based cohort studies including the Ageing Gene–Environment
Susceptibility-Reykjavik Study (AGES); the Atherosclerosis Risk in
Communities (ARIC) Study; the Cardiovascular Health Study; the
Framingham Heart Study; and two cohorts from the Rotterdam
Study. All studies collaborated within the CHARGE consortium neur-
ology working group. Details of the goals and organization of the
CHARGE consortium have previously been described (Psaty et al.,
2009). A total of 4773 hypertensive (AGES: 1959, ARIC: 157,
Cardiovascular Health Study: 1082, Framingham Heart Study: 940,
Rotterdam Study I: 269, Rotterdam Study II: 366) and 3772 normo-
tensive (AGES: 508, ARIC: 633, Cardiovascular Health Study: 1102,
Framingham Heart Study: 1218, Rotterdam Study I: 111, Rotterdam
Study II: 200) individuals were included in the present analyses.
Details of cohort selection, risk factor assessment and white matter
lesion assessment in each study, as well as genotyping procedures,
have been described (Fornage et al., 2011) and are given in more
detail in the Supplementary material. Briefly, each study performed
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genome wide genotyping on different platforms and after exten-
sive quality control all studies used their genotype data to impute
to the 2.5 million non-monomorphic, autosomal SNPs described in
the HapMap’s CEU (Utah residents with Northern and Western
European ancestry from the Centre de’Etude du Polymorphism
Humain collection) panel. The MRI scan protocol to detect white
matter lesions either used a fluid attenuation inversion recovery
sequence or proton density sequences. In participants from the
AGES-Reykjavik, Framingham Heart Study and Rotterdam Study,
white matter lesion volume was estimated on a quantitative scale
using custom written computer programmes based on an auto-
matic segmentation algorithm or a semi-automatic segmentation
analysis, in participants of the ARIC and Cardiovascular Health
Studies, white matter lesion volume was estimated on a
semi-quantitative scale. Within each study, a linear regression
model was used to evaluate the association of the SNP with the
natural log-transformed volume of white matter lesions. The
CHARGE consortium used the term white matter hyperintensity
as a synonym for white matter lesions. An additive genetic
model was assumed and significance of association was estimated
using a 1 degree of freedom trend test relating genotype dosage,
zero to two copies of the minor allele, to the phenotype. Analyses
were adjusted for age, sex and total intra-cranial volume (except
in the ARIC and Cardiovascular Health Studies, which inherently
adjust for intracranial volume). In addition, the ARIC and
Cardiovascular Health Studies adjusted for study site, and the
Framingham Heart Study adjusted for familial structure. Within
each study, analyses were performed separately in normo- and
hypertensives. Fixed-effect meta-analyses with inverse variance
weighting and forest plots were done according to hypertension
status using the Comprehensive Meta Analysis Version 2.2 soft-
ware (Borenstein et al., 2009). For estimating heterogeneity,
Cochran’s Q and I2 statistics were calculated.
Results
NOTCH3 sequence variations
We sequenced the NOTCH3 gene including the promoter, all
33 exons with the intronic flanking regions and the 30-untranslated
region in all 195 participants of the Austrian Stroke Prevention
Study with early confluent or confluent white matter lesions
or lacunes and in 82 randomly selected participants with normal
MRI. We found 42 SNPs scattered over the gene, with four
located in the promoter region, 30 in exons (19 non-synonymous,
11 synonymous), five within introns and three in the 30-untrans-
lated region. None of the SNPs affected a cysteine residue. In 13
exons, we did not detect mutations. According to the functional
domains of the Notch3 protein, 18 SNPs (11 non-synonymous,
seven synonymous) were in the epidermal growth factor-like re-
peats, two SNPs (one non-synonymous, one synonymous) in the
Lin12/Notch repeat domain, three (two non-synonymous, one
synonymous) in the Notch domain, one non-synonymous SNP in
the transmembrane domain, three SNPs (two non-synonymous,
one synonymous) in the ankyrin repeats domain and three (two
non-synonymous, one synonymous) in the low complexity region
domain. The distribution of SNPs over the NOTCH3 gene and
protein is shown in Fig. 1.
Common single nucleotide
polymorphisms and magnetic
resonance imaging findings
Among the 42 SNPs, nine had a minor allele frequency minor
allele frequency 55% in the subset of individuals with normal
MRI. All of these common SNPs were described in the Single
Nucleotide Polymorphism database and their characteristics are
given in Supplementary Table 1. All common SNPs, except for
rs1044009, which was excluded from further analyses, were in
Hardy Weinberg equilibrium. Linkage disequilibrium among the
SNPs in our cohort is shown in Fig. 2. We investigated the asso-
ciation between common SNPs and the presence of white matter
lesions and lacunes by assuming an additive genetic effect for the
minor alleles at each SNP (Supplementary Table 2). Carriers of the
minor allele at SNPs rs1043994, rs10404382 and at rs10423702
more commonly had white matter lesions. White matter lesions
were seen in 532 (79.2%) AA, 160 (85.1%) AG and 16 (94.1%)
GG genotype carriers, at rs1043994 (P = 0.022); in 488 (80.5%)
AA, 155 (87.1%) AC and 13 (92.9%) CC genotype carriers at
rs10404382 (P = 0.022); and in 535 (79%) individuals with the
Figure 1 Distribution of detected single nucleotide polymorphisms over the promoter region, exons and 30-untranslated region of the
NOTCH3 gene. Corresponding protein domains shown below. Functional annotation of mutations is colour coded: red
star = non-synonymous mutation; blue star = synonymous mutations; orange star = non-synonymous mutation occurring only in par-
ticipants with white matter lesions; green star = synonymous mutation occurred only in participants with white matter lesions; black
star = mutation in promoter region, 30 untranslated region and introns, respectively. ANK = ankyrin repeats; EGFR = epidermal growth
factor-like repeat; LCR = low complexity region; LNR = Lin12/Notch repeat; NOD = Notch domain; Prom = promoter;
RAM = RBP-J-associated molecule domain; TMD = transmembrane domain; 30-UTR = 30-untranslated region.
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AA, 163 (85.8%) with the AG and 14 (93.3%) with the GG
genotype at rs10423702 (P = 0.015). Logistic regression analysis
with adjustment for age (Model 1) and adjustment for
age, gender, hypertension, diabetes and cardiac disease (Model
2) revealed four of the common SNPs—rs1043994, s10404382,
rs10423702 and rs1043997—to be significantly related to the
presence of white matter lesions (Table 2). Stratification of the
analysis by the presence of hypertension showed that the effect
of the four SNPs was only present in hypertensives but not in
normotensives. As shown in Table 2, odds ratios were in the
range 2.1–3.4 for the presence of one minor allele at these
SNPs in hypertensives (P50.01), while there was no significant
association in normotensives. The frequency of white matter le-
sions over the genotypes upon stratification is given in the
Supplementary material. As can be seen in Table 3, the SNPs
were not only associated with the presence, but also with the
progression of white matter lesions. The effect was strongest in
subjects with hypertension. Importantly, the size and strength of
the association changed only marginally when additional adjustment
for baseline white matter lesions load was done (rs1043994:
b = 0.125; P = 0.07; rs10404382: b = 0.142; P = 0.05; rs10423702:
b = 0.141; P = 0.04; rs1043997: b = 0.087; P = 0.2). None of the
SNPs showed associations with the presence of lacunes
(rs1043994: odds ratio = 1.05, P = 0.89; rs10404382: odds
ratio = 1.21, P = 0.44; rs10423702: odds ratio = 1.03, P = 0.89;
rs1043997: odds ratio = 1.16, P = 0.54).
Replication study
We sought to replicate our results on the SNP rs10404382, which
was associated with the highest risk for white matter lesions in the
Austrian Stroke Prevention Study cohort, within the CHARGE con-
sortium including the AGES, ARIC, Cardiovascular Health Study,
Framlingham Heart Study and Rotterdam Studies I and II. There
were 4773 hypertensive (AGES: 1959, ARIC: 157, Cardiovascular
Health Study: 1082, Framlingham Heart Study: 940, Rotterdam
Study I: 269, Rotterdam Study II: 366) and 3772 normotensive
(AGES: 508, ARIC: 633, Cardiovascular Health Study: 1102,
Framingham Heart Study: 1218, Rotterdam Study I: 111,
Rotterdam Study II: 200) stroke-free elderly individuals involved in
the replication. Figure 3 displays the results of the meta-analyses
in the form of forest plots in these two subgroups as well as the
study-specific b-coefficients and 95% confidence intervals (95%
CIs). The C allele (allele frequency = 0.12; range = 0.11–0.16)
increased white matter lesions burden in hypertensives (P = 0.04;
b = 0.039; 95% CI 0.002; 0.076 on the transformed log
scale), but not in normotensives (P = 0.89; b = 0.002; 95% CI
0.028 to 0.033). The effect in hypertensives corresponds
to an increase of 3.5% of the overall mean white matter lesions
burden by one risk allele. There was no evidence of sub-
stantial between study heterogeneity in either subgroups (normoten-
sives: Cochran’s Q = 4.183, P = 0.53, I2 = 0.00; hypertensives:
Cochran’s Q = 7.59, P = 0.18, I2 = 34.15). At the individual study
Figure 2 Linkage disequilibrium plot of common single nucleotide polymorphisms together with inferred haplotype blocks. (Top)
Distribution of common SNPs on chromosome 19 over the NOTCH3 gene. The linkage disequilibrium values are R-squared with standard
(D0/LOD) colour scheme. Each black triangle depicts haplotype blocks.
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level, we saw the strongest and most significant effect in AGES
(P = 0.014; b = 0.108; 95% CI 0.022–0.194), and Cardiovascular
Health Study (P = 0.029; b = 0.62; 95% CI 0.006–0.118) repre-
senting the largest and oldest cohorts.
Clinical characteristics of rare single
nucleotide polymorphism carriers
We detected 33 rare SNPs (minor allele frequency 55%) includ-
ing 20 SNPs, which have not been described previously. As shown
in Table 4, three SNPs were located in the promoter region, 24 in
exons, three in introns and three in the 30-untranslated region.
Altogether, eight rare SNPs were C to T transitions at CpG di-
nucleotides. The 24 exonic SNPs included 18 non-synonymous
and six synonymous mutations. Fourteen SNPs were located in
epidermal growth factor-like repeats, two in Lin12/Notch repeat
domains, two in the Notch domain, one in the transmembrane
domain, three in the ankyrin repeat domains and two in the low
complexity region domain of Notch3. Of these SNPs, 15 were
exclusively detected in participants with severe white matter le-
sions, one in the promoter region, 11 in exons, one in an intron
and two in the 30-untranslated region. Importantly, nine of them
were non-synonymous SNPs. Clinical characteristics of the carriers
of these nine are shown in Table 5. All were 465 years, and with
one exception all had hypertension. In all subjects who underwent
repeated MRI scanning, white matter lesions progression was
observed. Temporal lobe hyperintensity, hyperintensity in the ex-
ternal capsule, lacunar infarcts or subcortical lacunar lesions were
seen in four of the nine individuals. None of these signal changes
Table 1 Association between common single nucleotide
polymorphisms and the presence of white matter lesions in
the Austrian Stroke Prevention Study cohort
SNP ID Minor
allele
Minor
allele
frequency
n Odds ratio
(95% CIs)
P-value
rs11882186a T 12.5 851 1.083 (0.720–1.630) 0.702
rs11882186b T 12.5 851 1.051 (0.694–1.591) 0.814
rs1043994a G 12.7 877 1.677 (1.093–2.572) 0.018
rs1043994b G 12.7 877 1.730 (1.121–2.669) 0.013
rs10404382a C 12.9 798 1.751 (1.100–2.786) 0.018
rs10404382b C 12.9 798 1.801 (1.127–2.879) 0.014
rs61749020a C 5.1 857 1.075 (0.606–1.908) 0.804
rs61749020b C 5.1 857 1.099 (0.615–1.964) 0.749
rs10423702a G 12.5 882 1.700 (1.103–2.621) 0.016
rs10423702b G 12.5 882 1.727 (1.114–2.676) 0.015
rs1043996a C 28.1 795 1.130 (0.835–1.530) 0.428
rs1043996b C 28.1 795 1.154 (0.850–1.567) 0.358
rs1043997a G 13.5 885 1.483 (0.998–2.201) 0.051
rs1043997b G 13.5 885 1.510 (1.013–2.249) 0.043
rs1044006a A 12.6 833 1.006 (0.690–1.467) 0.976
rs1044006b A 12.6 833 1.033 (0.705–1.514) 0.867
rs4809030a T 10.1 850 1.355 (0.846–2.171) 0.206
rs4809030b T 10.1 850 1.417 (0.879–2.284) 0.152
Odds ratios and P-values are given for the effect of the minor alleles, significant
SNPs are highlighted in bold.
a Logistic regression analyses Model 1 including age and the corresponding SNP.
b Logistic regression analyses Model 2 including age, sex, hypertension status,
diabetes status and the corresponding SNP.
n = number of successfully genotyped individuals; SNP ID = Identification number
of SNPs according to the Single Nucleotide Polymorphism database. Available
from: http://www.ncbi.nlm.nih.gov/SNP/
Table 2 Association of common single nucleotide polymorphisms with the presence of white matter lesions in
normotensive and hypertensive individuals
SNP ID Normotensives Hypertensives
n Odds ratio (95% CI) P-value n Odds ratio (95% CI) P-value
rs1043994 243 1.08 (0.571–2.044) 0.813 634 2.503 (1.342–4.667) 0.004
rs10404382 224 0.933 (0.482–1.896) 0.836 573 3.239 (1.559–6.728) 0.002
rs10423702 244 1.070 (0.558–2.054) 0.838 637 2.467 (1.324–4.598) 0.004
rs1043997 247 0.995 (0.558–1.776) 0.987 637 2.148 (1.204–3.834) 0.010
Significant SNPs are highlighted in bold. Odds ratios and P-values are given for the presence of one minor allele at the corresponding SNPs after adjustment for age, sex,
diabetes status and cardiac disease by logistic regression analyses.
n = number of successfully genotyped individuals; SNP ID = Identification number of SNP according to the Single Nucleotide Polymorphism database.
Table 3 The effect of common single nucleotide polymorphisms on white matter lesion progression measured as annual
white matter lesions load change in the Austrian Stroke Prevention Study cohort and hypertensive individuals
SNP ID Austrian Stroke Prevention Study cohort Hypertensives
n b (95% CI) P-value n b (95% CI) P-value
rs1043994 484 0.087 (0.000 to 0.238) 0.05 319 0.136 (0.043 to 0.365) 0.013
rs10404382 446 0.082 (0.018 to 0.235) 0.091 296 0.147 (0.053 to 0.392) 0.010
rs10423702 485 0.092 (0.007 to 0.247) 0.038 319 0.143 (0.055 to 0.198) 0.009
rs1043997 488 0.051 (0.046 to 0.180) 0.246 320 0.096 (0.016 to 0.304) 0.078
Significant SNPs are highlighted in bold. b-Coefficients and P-values are given for the presence of one minor allele at the corresponding SNPs after adjustment for age, sex,
hypertension (only in the entire cohort), diabetes status and cardiac disease by linear regression analyses.
n = number of successfully genotyped individuals; SNP ID = Identification number of SNP according to the Single Nucleotide Polymorphism database.
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can be considered specific for CADASIL. This also applies for the
lesion at the right temporal lobe because it is located adjacent to
the ventricular horn and does not affect the temporopolar white
matter, which is strongly associated with CADASIL (Fig. 4A).The
subject with the V764A variant showed not only the most pro-
nounced white matter lesion load and progression, but also had
slight anterior temporal lobe hyperintensity, considered to be a
specific MRI finding in CADASIL cases (Fig. 4A). Another individ-
ual with an A1450T exchange did not have anterior temporal lobe
hyperintensity, but had three other MRI findings suggestive of
CADASIL (Fig. 4B and C). Migraine without aura was reported
by one subject carrying the L1518M mutation. The Mini-Mental
State Examination score was within normal range in all
non-synonymous rare SNP carriers and there was no indication
of depression in these individuals. Stroke in first-degree relatives
was reported by two subjects with the H170R and S497L
mutations.
Functional assessment of rare
non-synonymous single nucleotide
polymorphisms
We assessed the functionality of the detected non-synonymous
rare SNPs by SIFT, PolyPhen2 and by homology modelling and
threading (Table 6). Using SIFT, eight amino acid substitutions—
H170R, P496L, V764A, H1133Q, V1183M, L1518M, D1823N
and V1952M—reached the optimum median sequence conserva-
tion values with scores between 0.00 and 0.05 and were predicted
to affect the protein function. Also, the A2190V substitution was
predicted to be functional but with low confidence. The SIFT
scores for the amino acid substitutions S497L, R1262L, A1450T
and G1710D, ranged between 0.06 and 0.87 and were predicted
as being tolerated. PolyPhen2 predicted H170R, A1450T, L1518M
and V1952M as probably damaging, and P496L, V1183M,
G1710D and D1823N as possibly damaging to protein function.
The method of homology modelling and threading to simulate
protein structure alterations upon mutation showed possible func-
tionality for the mutations H170R, P496L, S497L, V1183, R1262L,
A1450T, L1518M, D1823N and V1952M (Supplementary
Figs 1–9). Due to the different chemical and physical properties
of the replaced amino acids, the protein functionality could be
altered. Altogether there were six SNPs, H170R, P496L,
V1183M, L1518M, D1823N and V1952M, implicated by all
three bioinformatical tools as functional. Except for two of these
SNPs (V1183M and V1952M), they were exclusively or mainly
detected in subjects with severe white matter lesions. Table 6
summarizes the results of the functional SNP assessments.
Discussion
This is the first study investigating the distribution of sequence
variations in the NOTCH3 gene and assessing their role in
age-related cerebral small vessel disease in a community-based
cohort. We show that NOTCH3 is highly variable in the elderly
with both common and rare SNPs across the gene. Importantly,
mutations affecting cysteine residues, a characteristic of CADASIL
(Chabriat et al., 2009), were absent in the Austrian Stroke
Prevention Study cohort. Four common SNPs in strong linkage
disequilibrium significantly enhanced the risk for both the presence
and progression of white matter lesions. Importantly, the effect of
SNPs on both phenotypes was confined to hypertensives. We
found that the SNP, rs10404382, showing the strongest effect
on white matter lesions risk in the Austrian Stroke Prevention
Study cohort, was also significantly associated with white matter
lesions burden in an independent sample of 4773 elderly hyper-
tensive stroke-free individuals of European descent within the
CHARGE consortium, including the AGES, ARIC, Cardiovascular
Health Study, Framingham Hear Study and Rotterdam Studies I
and II. We observed nine rare non-synonymous SNPs, which were
only present in subjects with severe white matter lesions.
Bioinformatical tools consistently implicated three of these SNPs
to be functional. Clinical assessment of the carriers of the nine
SNPs did not reveal CADASIL-specific findings. Beside white
Figure 3 Forest plots for the single nucleotide polymorphism
rs10404382 within the CHARGE consortium in normotensives
(Panel A) and in hypertensives (Panel B). Individual studies
are plotted against the individual effect sizes (point estimates
of the b-coefficients for white matter lesions as continuous trait,
log transformed). The size of the box is inversely proportional to
the estimated variance of the effect-size estimator. Horizontal
lines are the 95% CIs. The diamond represents the meta-analytic
effect size. AGES = Aging Gene-Environment Susceptibility-
Rejkjavik Study; ARIC = Atherosclerosis Risk in Communities
Study; CHS = Cardiovascular Health Study; FHS = Framingham
Heart Study; RS = Rotterdam Study.
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matter lesions, they showed temporal lobe hyperintensity, hyper-
intensity in the external capsule, lacunar infarcts and subcortical
lacunar lesions in four, the presence of migraine in one and stroke
in first-degree relatives of two individuals. Although such findings
have been reported in cases of CADASIL, it is important to realize
that the lesion at the anterior temporal lobe was not typical for the
disease as it did not affect the temporopolar white matter. All
other MRI lesion types also occur in elderly subjects without
CADASIL. Additionally, subjects with migraine had no aura,
which would be more indicative for CADASIL.
Of particular interest is our finding indicating hypertension-de-
pendent effects of NOTCH3 variants on both prevalence and pro-
gression of white matter lesions. It is conceivable that the
association is mediated by an impaired vascular response to hyper-
tension due to Notch3 dysfunction. In the adult brain, Notch3 is
expressed in the vascular smooth muscle cells of small vessels and
it is essential for maintaining normal vascular structure and func-
tion (Ayata, 2010; Joutel et al., 2010). Furthermore, it also plays a
central role in the autoregulation of cerebral blood flow and cere-
bral resistance (Joutel et al., 2010). Autoregulation assures that
under fluctuating blood pressure, cerebral blood flow remains ad-
equate. The white matter is particularly sensitive to ischaemia
(Pantoni et al., 1996) and white matter lesions are thought
to be ischaemic manifestations of chronic hypoperfusion with de-
generation of myelinated fibres due to repeated selective oligo-
dendrocyte death (Pantoni, 2010). In this context, it is important
to note that not only hypertension, but also diurnal blood pres-
sure abnormalities have been shown to be associated with
white matter lesions (Gomez-Angelats et al., 2004). NOTCH3
knockout mice showed an enhanced susceptibility to ischaemia
Table 4 List and characteristics of rare single nucleotide polymorphisms
SNP ID cDNA Allele Exon Function Amino acid
change
Domain Novel WML+,
n = 195
WML,
n = 82
1 622 C / T Prom 50 near gene – – No 0 1
2 462 G / C Prom 50 near gene – – No 1 0
3 328 A / C Prom 50 near gene – – No 1 3
4 274 + 16 G / A 2 intron – – No 0 1
5a 384 G / A 3 NS R103Q EGFR 2 Yes 0 1
6 585 A / G 4 NS H170R EGFR 4 Yes 1 0
7 847 C / A 5 S T257T EGFR 6 Yes 0 1
8 1563 C / T 9 NS P496L EGFR 12 No 8 2
9a 1566 C / T 9 NS S497L EGFR 12 Yes 1 0
10 1581 C / T 10 NS S502F EGFR 12 Yes 0 1
11a 1717 C / T 11 S G547G EGFR 14 Yes 1 0
12a 1801 G / A 11 S T575T EGFR 14 No 6 1
13 2367 T / C 14 NS V764A EGFR 19 Yes 1 0
14 2486 + 452 C / G 15 Intron – – No 2 0
15 3134 G / C 19 NS A1020P EGFR 26 No 1 3
16 3475 C / A 21 NS H1133Q EGFR 29 No 11 4
17a 3623 G / A 22 NS V1183M EGFR 30 No 0 2
18 3780 A / T 22 NS H1235L EGFR 31 No 3 2
19 3861 G / T 23 NS R1262L EGFR 32 Yes 1 0
20 3913 + 11 G / A 23 intron – – Yes 0 1
21 4424 G / A 24 NS A1450T LNR 2 Yes 1 0
22 4426 C / T 24 S A1450A LNR 2 Yes 1 0
23 4628 C / A 25 NS L1518M NOD Yes 1 0
24 4715 C / G 25 NS L1547V NOD Yes 1 1
25 5205 G / A 28 NS G1710D TMD Yes 1 0
26a 5543 G / A 30 NS D1823N ANK 1 Yes 1 0
27 5602 T / C 30 S A1842A ANK 1 No 0 2
28 5930 G / A 32 NS V1952M ANK 5 Yes 2 3
29 6514 A / C 33 S A2146A LCR No 2 3
30a 6645 C / T 33 NS A2190V LCR Yes 1 0
31a 7045 C / T 33 30-UTR – – Yes 2 0
32 7138 C / T 33 30-UTR – – Yes 2 1
33 7245 A / C 33 30-UTR – – Yes 4 0
Non-synonymous SNPs detected only in individuals with severe white matter lesions are in bold.
a SNPs at CpG sites.
ANK = ankyrin repeat; cDNA = position of the SNP according to the NOTCH3 cDNA sequence, EGFR = epidermal growth factor-like repeat; LCR = low complexity region;
LNR = Lin12/Notch repeat; NOD = Notch domain; NS = non-synonymous mutation, prom: promoter; S = synonymous mutation; SNP ID = Identification number of rare
SNP according to their position in the NOTCH3 gene; TMD = transmembrane domain; WML + = individuals with severe white matter lesions, WML = individuals with
normal MRI.
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(Arboleda-Velasquez et al., 2008). Notch3 is also involved in the
local vascular reaction to mechanical stress and to hypertension by
modulating vascular smooth muscle cell phenotype and by affect-
ing the balance between their proliferation and apoptosis (Morrow
et al., 2005, 2008). The observed hypertension dependent effect
of NOTCH3 variants is opposite to our earlier observations on the
angiotensinogen promoter B haplotype, which affects the risk for
white matter lesions independently of the presence of hyperten-
sion (Schmidt et al., 2001), probably by leading to an
over-expression of angiotensinogen in astrocytes (Schmidt et al.,
2004). Astrocytes and vascular smooth muscle cells are major con-
stituents of the neurovascular unit, and thus these findings support
a possible role of this structure in the development of age-related
white matter lesions.
Although the role of Notch3 in the development of age-related
cerebral small vessel disease can easily be envisioned, it remains
speculative how the described mutations alter its function. The
common SNPs associated with white matter lesions are synonym-
ous or intronic mutations and are in strong linkage disequilibrium
with each other. They are most probably not causal themselves
but rather mark the presence of yet undetected functional muta-
tion(s) in linkage disequilibrium. On the other hand, recent evi-
dence also suggests that synonymous mutations are able to alter
translational efficiency of a gene and, therefore, might be patho-
genic (Berleant et al., 2009).
Typically, CADASIL mutations are located within epidermal
growth factor-like repeats, they cluster in exons 3 and 4 and are
characterized by an uneven number of cysteine residues. It has
been argued that CADASIL mutations are most probably gain of
function mutations because they occur in regions with high se-
quence diversity and low evolutionary conservation and because
of their stereotyped nature (Donahue and Kosik, 2004) although a
recent report rather supports a hypomorphic nature at least for
two CADASIL mutations (Arboleda-Velasquez et al., 2011).
Possible new functions acquired by the mutations are misfolding
of the protein leading to aggregation or impaired protein–protein
interactions. Contrary to the stereotypic nature of CADASIL mu-
tations and their clustering in epidermal growth factor-like repeats,
the 42 different point mutations we detected in the normal elderly
are dispersed over the whole gene and the non-synonymous
changes lead to diverse amino acid substitutions. This finding is
more supportive for loss of function or hypomorphic mutations.
This is also in line with the observed gene dose effect for the risk
alleles. Non-cysteine (R75P) mutation in Korean and Japanese
CADASIL patients with granular osmiophilic material depositions
have been previously reported (Kim et al., 2006; Muzino et al.,
2008). These patients manifested multiple cerebral infarctions and
white matter lesions, which importantly did not extend to the
temporal lobe. The authors hypothesized that the R75P mutation
lead to a destabilization of the adjacent disulphide bridges be-
tween the cysteine residues. Recently, another non-cysteine
amino acid substitution, L1515P, has been described in a French
patient with cerebral small vessel disease lacking granular osmio-
philic material deposits, and Notch3 extracellular domain accumu-
lation. This mutation led to a destabilization of the Notch3
heterodimer and to a constitutive activation of the Notch3 recep-
tor (Fouillade et al., 2008). This mutation is located within aT
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leucine zipper motif of the Notch domain close to the L1518M
mutation detected in our cohort. Seven of the nine rare SNP car-
riers showed some ‘CADASIL-like’ clinical signs or MRI features,
which further supports functionality for the SNPs H170R, P496L,
L1518M and D1823N. Importantly, none of the rare SNP carriers
showed all characteristic symptoms of CADASIL, probably indicat-
ing the central role of cysteine mutations in this disease. Although
the individual with the D1823N did not present any CADASIL-like
signs, she had one of the most severe white matter lesions and
this mutation was predicted by all three in silico methods as func-
tional. The clinical characteristics of the R1262L carrier were simi-
lar, but for this mutation in silico analyses were ambiguous. In
addition to the deepening of our understanding about the patho-
genesis of age-related cerebral small vessel disease, knowledge of
Table 6 Predicted consequences of amino acid substitutions on protein function of the non-synonymous rare single nu-
cleotide polymorphisms observed only in individuals with severe white matter lesion by SIFT and Polyphen2 analysis and
with homology modelling and threading
Exon Amino acid change Domain Prediction SIFT Prediction polyphen2 Molecular modelling
3 R103Q EGFR 2 Tolerated Benign No significant structural change
4 H170R EGFR 4 Affected Probably damaging Additional H-bond
9 P496L EGFR 12 Affected Possibly damaging Possible stronger van der Waals interactions
9 S497L EGFR 12 Tolerated Benign Possible change in EGFR folding
10 S502F EGFR 12 Tolerated Benign No significant structural change
14 V764A EGFR 19 Affected Benign No significant structural change
19 A1020P EGFR 26 Tolerated Benign Predicted structure is not reliable
21 H1133Q EGFR 29 Affected Benign No significant structural change
22a V1183M EGFR 30 Affected Possibly damaging Possible EGF-EGF interaction
22 H1235L EGFR 31 Tolerated Benign Predicted structure is not reliable
23 R1262L EGFR 32 Tolerated Benign may influence EGFR-EGFR folding
24 A1450T LNR 2 Tolerated Probably damaging Additional H-bond
25 L1518M NOD Affected Probably damaging Disruption of the leucine zipper pattern
25 L1547V NOD Tolerated Benign No significant structural change
28 G1710D TMD Tolerated Possibly damaging No results
30 D1823N ANK 1 Affected Possibly damaging Possible ANK-ANK interaction
32a V1952M ANK 5 Affected Probably damaging Additional H-bond
33 A2190V LCR Tolerated Benign No results
a SNPs not supported clinically but by all three bioinformatic tools; SNPs supported both clinically as well as by all three bioinformatic tools are given in bold.
ANK = ankyrin repeat; EGFR = epidermal growth factor-like repeat; prom: promoter; LCR = low complexity region; LNR = Lin12/Notch repeat; NOD = Notch domain;
TMD = transmembrane domain.
Figure 4 MRI findings suggestive of CADASIL in carriers of rare non-synonymous single nucleotide polymorphisms. Axial
fluid-attenuated inversion recovery MRI images. (A) Subject 1350 with a V764A amino acid exchange showing a hyperintense rounded
area of signal hyperintensity in the temporal lobe directly adjacent to the temporal horn of the lateral ventricle (arrow). Although signal
changes at this location are not typically seen with age-related white matter changes, the abnormality can also not be considered specific
for CADASIL, because CADASIL lesions usually extend to the most anterior parts of the temporopolar white matter. (B) Subcortical lacunar
lesions which have been reported with CADASIL (van den Boom et al., 2002) are shown in the subinsular region and operculum of the
frontal lobe bilaterally. (C) demonstrates confluent hyperintensity of the external capsule (arrow), a finding that has high sensitivity, but
low specificity in CADASIL (Markus et al., 2002).
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the mutation spectrum at NOTCH3 in the normal elderly should
also facilitate the interpretation of atypical non-cysteine mutations
in CADASIL diagnostics.
The strengths of our study are that it investigates for the first
time a community based, normal elderly population for the pres-
ence of NOTCH3 gene variations and provides a comprehensive
list of SNPs in Europeans over the promoter, all exons and 30-
untranslated regions. Extensive phenotyping and the availability
of follow-up data in the Austrian Stroke Prevention Study cohort
allowed the investigation of the effect of mutations both
cross-sectionally and in longitudinal fashion. Further on the asso-
ciation of the common SNP, rs10404382, with the strongest effect
on white matter lesions in the original cohort was replicated in a
large sample of elderly individuals of European descent. Further
investigation of this SNP (or rs1043994 and rs10423702 that are
in strong linkage disequilibrium with it) in different cohorts and
ethnic groups are warranted to solidify their relevance in white
matter lesions risk. The functional relevance of the reported rare
mutations is still speculative and further studies on relatives of the
carriers as well as experimental studies are needed to establish
causality.
A potential problem of our study is that we have performed
multiple statistical tests in order to explore whether genetic vari-
ations at the NOTCH3 gene are relevant in age-related cerebral
small vessel disease. We investigated two primary phenotypes,
white matter lesions and lacunes and the secondary phenotype
white matter lesions progression. We investigated two statistical
models in the regression analyses, once we adjusted for age and
then for additional possible confounders including sex, hyperten-
sion, cardiac disease and diabetes to see if the effect size was
changed. We also tested nine common SNPs for associations
with white matter lesions and then followed up on the most sig-
nificant four, which were highly correlated (R240.9). Finally, we
explored the association in two subgroups by stratifying on hyper-
tension. In the results section, we did not adjust for multiple test-
ing, as both the outcome measures and the predictive SNPs are
correlated, and an adequate adjustment is therefore difficult.
Although due to multiple testing, the possibility of false positive
findings in the discovery sample is enhanced, it should be noted
that the proportion of statistically significant findings was much
45%, which one would expect by chance. Nevertheless, the most
important support for the assertion that findings in the Austrian
Stroke Prevention Study cohort are not due to chance comes from
the replication of our findings both in the individual cohorts AGES
and Cardiovascular Health Study as well as in meta-analyses of
large independent samples of stroke-free individuals within the
CHARGE consortium.
In summary, our study shows that the NOTCH3 gene is highly
variable in the elderly and that common variants at the NOTCH3
gene increase the risk of age-related white matter lesions in
the presence of hypertension. Additional investigations are
required to identify the mode of action of described NOTCH3
variants. Although conceivable, it needs to be explored as to
whether Notch3 signalling per se might be a relevant pathway
in the development of cerebral small vessel disease with
advancing age.
Acknowledgements
The Austrian Stroke Prevention Study: The authors thank the staff
and the participants for their valuable contributions. We thank
Birgit Reinhart for her long-term administrative commitment, Elfi
Hofer for the technical assistance at creating the DNA bank, Ing.
Johann Semmler and Anita Harb for DNA sequencing and DNA
analyses by TaqMan assays and Irmgard Poelzl for supervising the
quality management processes after ISO9001 at the biobanking
and DNA analyses.
Funding
The Austrian Stroke Prevention Study: This work was supported by
the Austrian Science Fund (FWF) grant number P20545-P05 to HS
and P13180 to RS. The Medical University of Graz supports the
database of the Austrian Stroke Prevention Study. Aging Gene–
Environment Susceptibility – Reykjavik Study: The research has
been funded by NIA contract N01-AG-12100 with contributions
from NEI, NIDCD and NHLBI, the NIA Intramural Research
Program, Hjartavernd (the Icelandic Heart Association) and the
Althingi (the Icelandic Parliament). The Atherosclerosis Risk in
Communities Study: The research is carried out as a collaborative
study supported by National Heart, Lung and Blood Institute con-
tracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-
55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, and
grants R01-HL087641 and R01-HL093029; National Human
Genome Research Institute contract U01-HG004402; and
National Institutes of Health contract HHSN268200625226C.
Infrastructure was partly supported by Grant Number
UL1RR025005, a component of the National Institutes of Health
and NIH Roadmap for Medical Research. Cardiovascular Health
Study: The research reported in this article was supported by con-
tract numbers N01-HC-85079 through N01-HC-85086, N01-HC-
35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-
HC-45133, grant numbers U01 HL080295 and R01-HL087652
from the National Heart, Lung, and Blood Institute, with additional
contribution from the National Institute of Neurological Disorders
and Stroke. A full list of principal investigators and institutions can
be found at http://www.chs–nhlbi.org/pi.htm. DNA handling and
genotyping was supported in part by National Centre for Research
Resources grant M01RR00425 to the Cedars-Sinai General Clinical
Research Centre Genotyping core and National Institute of
Diabetes and Digestive and Kidney Diseases grant DK063491 to
the Southern California Diabetes Endocrinology Research Centre.
Framingham Heart Study: From the Framingham Heart Study of
the National Heart Lung and Blood Institute of the National
Institutes of Health and Boston University School of Medicine.
This work was supported by the National Heart, Lung and Blood
Institute’s Framingham Heart Study (Contract No. N01-HC-
25195) and its contract with Affymetrix Inc. for genotyping ser-
vices (Contract No. N02-HL-6-4278). A portion of this research
utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by
the Robert Dawson Evans Endowment of the Department of
Medicine at Boston University School of Medicine and Boston
Medical Center. Analyses reflect intellectual input and resource
NOTCH3 and cerebral small vessel disease Brain 2011: 134; 3384–3397 | 3395
 at Institute of Social Studies on June 28, 2012
http://brain.oxfordjournals.org/
D
ow
nloaded from
 
development from the Framingham Heart Study investigators par-
ticipating in the SNP Health Association Resource (SHARe) project.
This study was also supported by grants from the National
Institute of Neurological Disorders and Stroke (NS17950) and
the National Institute of Ageing (AG08122, AG16495,
AG033193, AG031287). Rotterdam Study: The GWA database
of the Rotterdam Study was funded through the Netherlands
Organization of Scientific Research (NWO; nr.
175.010.2005.011). This study was further supported by the
Netherlands Genomics Initiative (NGI)/ NWO project 050-060-
810. The Rotterdam Study is supported by the Erasmus Medical
Centre and University, Rotterdam; the NWO, the Netherlands
Organization for Health Research and Development (ZonMw),
the Research Institute for Diseases in the Elderly (RIDE), the
Ministry of Education, Culture and Science, the Ministry for
Health, Welfare and Sports, the European Commission (DG XII)
and the Municipality of Rotterdam.
Supplementary material
Supplementary material is available at Brain online.
References
Adib-Samii P, Brice G, Martin RJ, Markus HS. Clinical spectrum of
CADASIL and the effect of cardiovascular risk factors on phenotype:
study in 200 consecutively recruited individuals. Stroke 2010; 41:
630–4.
Arboleda-Velasquez JF, Manent J, Lee JH, Tikka S, Ospina C,
Vanderburg CR, et al. Hypomorphic Notch 3 alleles link Notch signal-
ing to ischemic cerebral small-vessel disease. Proc Natl Acad Sci USA
2011; 108: E128–35.
Arboleda-Velasquez JF, Zhou Z, Shin HK, Louvi A, Kim HH, Savitz SI,
et al. Linking Notch signaling to ischemic stroke. Proc Natl Acad Sci
USA 2008; 105: 4856–61.
Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate con-
trol and signal integration in development. [Review]. Science 1999;
284: 770–6.
Atwood LD, Wolf PA, Heard-Costa NL, Massaro JM, Beiser A,
D’Agostino RB, et al. Genetic variation in white matter hyperintensity
volume in the Framingham Study. Stroke 2004; 35: 1609–13.
Ayata C. CADASIL: experimental insights from animal models. [Review].
Stroke 2010; 41: S129–34.
Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization
of LD and haplotype maps. Bioinformatics 2005; 21: 263–5.
Berleant D, White M, Pierce E, Tudoreanu E, Boeszoermenyi A,
Shtridelman Y, et al. The genetic code-more than just a Table.
[Review]. Cell Biochem Biophys 2009; 55: 107–16.
Borenstein M, Hedges LV, Higgins JP, Rothstein HR. Introduction to
meta-analysis. West Sussex, UK: John Wiley & Sons, Ltd; 2009.
Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den
Hout JH, et al. Cerebral white matter lesions, vascular risk factors, and
cognitive function in a population-based study: the Rotterdam Study.
Neurology 1994; 44: 1246–52.
Carmelli D, DeCarli C, Swan GE, Jack LM, Reed T, Wolf PA, et al.
Evidence for genetic variance in white matter hyperintensity volume
in normal elderly male twins. Stroke 1998; 29: 1177–81.
Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG.
Cadasil. [Review]. Lancet Neurol 2009; 8: 643–53.
Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, et al.
Clinical spectrum of CADASIL: a study of 7 families. Cerebral
autosomal dominant arteriopathy with subcortical infarcts and leu-
koencephalopathy. Lancet 1995; 346: 934–9.
Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Mohr JP. The
natural history of CADASIL: a pooled analysis of previously published
cases. Stroke 1999; 30: 1230–3.
Dichgans M, Mayer M, Uttner I, Bru¨ning R, Mu¨ller-Ho¨cker J, Rungger G,
et al. The phenotypic spectrum of CADASIL: clinical findings in 102
cases. Ann Neurol 1998; 44: 31–9.
Domenga V, Fardoux P, Lacombe P, Monet M, Maciazek J, Krebs LT,
et al. Notch3 is required for arterial identity and maturation of vascular
smooth muscle cells. Genes Dev 2004; 18: 2730–5.
Donahue CP, Kosik KS. Distribution pattern of Notch3 mutations sug-
gests a gain-of-function mechanism for CADASIL. Genomics 2004; 83:
59–65.
Folstein M, Folstein S, McHugh P. Mini Mental State: a practical method
for grading the cognitive state of patients for the clinician. J Psychiatr
Res 1975; 12: 189–98.
Fornage M, Debette S, Bis JC, Schmidt H, Ikram AM, Dufouil C, et al. A
locus on chromosome 17q25 influences burden of MRI-defined cere-
bral white matter hyperintensities in individuals of European descent.
Ann Neurol 2011; 69: 928–39.
Fouillade C, Chabriat H, Riant F, Mine M, Arnoud M, Magy L, et al.
Activating NOTCH3 mutation in a patient with small-vessel-disease of
the brain. Hum Mutat 2008; 29: 452–9.
Go´mez-Angelats E, de La Sierra A, Sierra C, Parati G, Mancia G, Coca A.
Blood pressure variability and silent cerebral damage in essential hyper-
tension. Am J Hypertens 2004; 17: 696–700.
Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an en-
vironment for comparative protein modelling. Electrophoresis 1997;
18: 2714–23.
Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, et al.
LADIS Study Group. Changes in white matter as determinant of global
functional decline in older independent outpatients: three year
follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ
2009; 339: b2477.
Janke W, Debus G. Die Eigenschaftswoerterliste (EWL). Handanweisung.
Hogrefe: Goettingen; 1978.
Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al.
Notch3 mutations in CADASIL, a hereditary adult-onset condition
causing stroke and dementia. Nature 1996; 383: 707–10.
Joutel A, Monet-Lepreˆtre M, Gosele C, Baron-Menguy C, Hammes A,
Schmidt S, et al. Cerebrovascular dysfunction and microcirculation
rarefaction precede white matter lesions in a mouse genetic model
of cerebral ischemic small vessel disease. J Clin Invest 2010; 120:
433–45.
Kelley LA, Sternberg MJ. Protein structure prediction on the
Web: a case study using the Phyre server. Nat Protoc 2009; 4:
363–71.
Kim Y, Choi EJ, Choi CG, Kim G, Choi JH, Yoo HW, et al. Characteristics
of CADASIL in Korea: a novel cysteine–sparing Notch3 mutation.
Neurology 2006; 66: 1511–6.
Launer LJ, Berger K, Breteler MM, Dufouil C, Fuhrer R, Giampaoli S,
et al. Regional variability in the prevalence of cerebral white matter
lesions: an MRI study in 9 European countries (CASCADE).
Neuroepidemiology 2006; 26: 23–9.
Li Z, Yu H, Zhuang W, Mukamel S. Geometry and excitation
energy fluctuations of NMA in aqueous solution with CHARMM,
AMBER, OPLS, and GROMOS force fields: implications for
protein ultraviolet spectra simulation. Chem Phys Lett 2008; 452:
78–83.
Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, Manolio TA,
Lefkowitz D, Jungreis C, et al. Incidence, manifestations, and predict-
ors of worsening white matter on serial cranial magnetic resonance
imaging in the elderly: the Cardiovascular Health Study. Stroke
2005; 36: 56–61.
Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, Crosby AH,
et al. Diagnostic strategies in CADASIL. Neurology 2002; 59:
1134–8.
3396 | Brain 2011: 134; 3384–3397 H. Schmidt et al.
 at Institute of Social Studies on June 28, 2012
http://brain.oxfordjournals.org/
D
ow
nloaded from
 
Mizuno T, Muranishi M, Torugun T, Tango H, Nagakane Y, Kudeken T,
et al. Two Japanese CADASIL families exhibiting Notch3 mutation
R75P not involving cysteine residue. Inter Med 2008; 47: 2067–72.
Morrow D, Guha S, Sweeney C, Birney Y, Walshe T, O’Brien C, et al.
Notch and vascular smooth muscle cell phenotype. [Review]. Circ Res
2008; 103: 1370–82.
Morrow D, Sweeney C, Birney YA, Cummins PM, Walls D,
Redmond EM, et al. Cyclic strain inhibits Notch receptor signaling in
vascular smooth muscle cells in vitro. Circ Res 2005; 96: 567–75.
O’Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L,
et al. Vascular cognitive impairment. [Review]. Lancet Neurol 2003; 2:
89–98.
Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vul-
nerable to ischemia. Stroke 1996; 27: 1641–7.
Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical
characteristics to therapeutic challenges. Lancet Neurol 2010; 9:
689–701.
Psaty BM, O’Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI,
et al. Cohorts for Heart and Aging Research in Genomic Epidemiology
(CHARGE) Consortium: Design of prospective meta-analyses of
genome-wide association studies from five cohorts. Circ Cardiovasc
Genet 2009; 2: 73–80.
Reyes S, Viswanathan A, Godin O, Dufouil C, Benisty S, Hernandez K,
et al. Apathy: a major symptom in CADASIL. Neurology 2009; 72:
905–10.
Rosano C, Brach J, Longstreth WT Jr, Newman AB. Quantitative meas-
ures of gait characteristics indicate prevalence of underlying subclinical
structural brain abnormalities in high-functioning older adults.
Neuroepidemiology 2006; 26: 52–60.
Schmidt H, Fazekas F, Kostner GM, van Duijn CM, Schmidt R.
Angiotensinogen gene promoter haplotype and microangiopathy-
related cerebral damage: results of the Austrian Stroke Prevention
Study. Stroke 2001; 32: 405–12.
Schmidt H, Aulchenko YS, Schweighofer N, Schmidt R, Frank S,
Kostner GM, et al. Angiotensinogen promoter B-haplotype associated
with cerebral small vessel disease enhances basal transcriptional activ-
ity. Stroke 2004; 35: 2592–7.
Schmidt R, Fazekas F, Kapeller P, Schmidt H, Hartung HP. MRI white
matter hyperintensities: three-year follow-up of the Austrian Stroke
Prevention Study. Neurology 1999; 53: 132–9.
Schmidt R, Lechner H, Fazekas F, Niederkorn K, Reinhart B, Grieshofer P,
et al. Assessment of cerebrovascular risk profiles in healthy persons:
definition of research goals and the Austrian Stroke Prevention Study
(ASPS). Neuroepidemiology 1994; 13: 308–13.
Schmidt R, Ropele S, Enzinger C, Petrovic K, Smith S, Schmidt H, et al.
White matter lesion progression, brain atrophy, and cognitive de-
cline: the Austrian stroke prevention study. Ann Neurol 2005; 58:
610–6.
Schmidt R, Petrovic K, Ropele S, Enzinger C, Fazekas F. Progression of
leukoaraiosis and cognition. Stroke 2007; 38: 2619–25.
Srikanth V, Beare R, Blizzard L, Phan T, Stapleton J, Chen J, et al.
Cerebral white matter lesions, gait, and the risk of incident falls: a
prospective population-based study. Stroke 2009; 40: 175–80.
Sussman JL, Abola EE, Lin D, Jiang J, Manning NO, Prilusky J. The pro-
tein data bank. Bridging the gap between the sequence and 3D struc-
ture world. Genetica 1999; 106: 149–58.
van den Boom R, Lesnik Oberstein SA, Ferrari MD, Haan J, van
Buchem MA. Cerebral autosomal dominant arteriopathy with subcor-
tical infarcts and leukoencephalopathy: MR imaging findings at differ-
ent ages-3rd–6th decades. Radiology 2003; 229: 683–90.
Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ,
Breteler MM. Silent brain infarcts and the risk of dementia and cog-
nitive decline. N Engl J Med 2003b; 348: 1215–22.
Wang T, Baron M, Trump D. An overview of Notch3 function in vascular
smooth muscle cells. [Review]. Prog Biophys Mol Biol 2008; 96:
499–509.
NOTCH3 and cerebral small vessel disease Brain 2011: 134; 3384–3397 | 3397
 at Institute of Social Studies on June 28, 2012
http://brain.oxfordjournals.org/
D
ow
nloaded from
 
